Russell Investments Group’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $303K | Buy |
23,318
+11,490
| +97% | +$149K | ﹤0.01% | 2520 |
|
|
2025
Q1 | $125K | Buy |
11,828
+11,799
| +40,686% | +$125K | ﹤0.01% | 2706 |
|
|
2024
Q4 | $492 | Sell |
29
-2,829
| -99% | -$48K | ﹤0.01% | 3612 |
|
|
2024
Q3 | $66.3K | Buy |
2,858
+792
| +38% | +$18.4K | ﹤0.01% | 2735 |
|
|
2024
Q2 | $50.3K | Buy |
2,066
+872
| +73% | +$21.2K | ﹤0.01% | 2762 |
|
|
2024
Q1 | $40.3K | Buy |
+1,194
| New | +$40.3K | ﹤0.01% | 2696 |
|
|
2023
Q4 | – | Sell |
-24
| Closed | -$613 | – | 3209 |
|
|
2023
Q3 | $613 | Buy |
+24
| New | +$613 | ﹤0.01% | 3385 |
|
|
2023
Q2 | – | Sell |
-4,300
| Closed | -$103K | – | 3449 |
|
|
2023
Q1 | $103K | Buy |
+4,300
| New | +$103K | ﹤0.01% | 2585 |
|